How big is the Fluid Biopsy Market?

The Fluid Biopsy Market size is expected to reach USD 6.11 billion in 2024 and grow at a CAGR of 16.40% to reach USD 13.05 billion by 2029. Read More

What is the current Fluid Biopsy Market size?

In 2024, the Fluid Biopsy Market size is expected to reach USD 6.11 billion. Read More

Who are the key players in Fluid Biopsy Market?

Bio-Rad Laboratories, Guardant Health, Horizon Discovery, Qiagen NV and LungLife AI Inc. are the major companies operating in the Fluid Biopsy Market. Read More

Which is the fastest growing region in Fluid Biopsy Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Fluid Biopsy Market?

In 2024, the North America accounts for the largest market share in Fluid Biopsy Market. Read More

What years does this Fluid Biopsy Market cover, and what was the market size in 2023?

In 2023, the Fluid Biopsy Market size was estimated at USD 5.25 billion. The report covers the Fluid Biopsy Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Fluid Biopsy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Fluid Biopsy Market Share

Statistics for the 2023 & 2024 Fluid Biopsy market share, created by Mordor Intelligence™ Industry Reports. Fluid Biopsy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Fluid Biopsy Industry

The fluid biopsy market is competitive and consists of a few major players. In terms of market share, these players currently dominate the market. Some of the major players are Bio-Rad Laboratories, LungLife AI Inc. (Cynvenio), Guardant Health, Horizon Discovery, and Qiagen.